Japan Animal Referral Medical Center Co., Ltd. (6039.T)
- Previous Close
2,636.00 - Open
2,635.00 - Bid 2,650.00 x --
- Ask 2,678.00 x --
- Day's Range
2,635.00 - 2,666.00 - 52 Week Range
1,832.00 - 2,755.00 - Volume
6,300 - Avg. Volume
6,012 - Market Cap (intraday)
6.891B - Beta (5Y Monthly) 0.49
- PE Ratio (TTM)
14.85 - EPS (TTM)
179.51 - Earnings Date May 15, 2025
- Forward Dividend & Yield 74.00 (2.81%)
- Ex-Dividend Date Mar 28, 2025
- 1y Target Est
--
Japan Animal Referral Medical Center Co., Ltd. owns and operates medical centers for animals in Japan. Its veterinary hospital provides advanced medical care service for dogs and cats. The company's medical center comprises cardiology, respiratory, urology, gastroenterology, oncology, neurology, orthopedics, ophthalmology, radiology and imaging, and anesthesiology departments. It also provides professional training services, such as clinical training and treatment; and conducts research and development projects, including genetic testing, immunotherapy, and regenerative medicine. Japan Animal Referral Medical Center Co., Ltd. was incorporated in 2005 and is headquartered in Kawasaki, Japan.
www.jarmec.co.jp256
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: 6039.T
View MorePerformance Overview: 6039.T
Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 6039.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 6039.T
View MoreValuation Measures
Market Cap
6.81B
Enterprise Value
9.70B
Trailing P/E
14.69
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.46
Price/Book (mrq)
1.76
Enterprise Value/Revenue
2.00
Enterprise Value/EBITDA
7.85
Financial Highlights
Profitability and Income Statement
Profit Margin
10.32%
Return on Assets (ttm)
5.41%
Return on Equity (ttm)
13.27%
Revenue (ttm)
5.1B
Net Income Avi to Common (ttm)
525.6M
Diluted EPS (ttm)
179.51
Balance Sheet and Cash Flow
Total Cash (mrq)
1.03B
Total Debt/Equity (mrq)
90.24%
Levered Free Cash Flow (ttm)
--